Connect
← Return to New research on length of ADT therapy for patients with RT
Discussion
New research on length of ADT therapy for patients with RT
Prostate Cancer | Last Active: 1 hour ago | Replies (48)Comment receiving replies
Thank you, Phil.
Yes, I'm planning on 12 months.
I'm Gleason 4+3, very small, didn't even show on post biopsy MRI. High risk comes from 28 PSA prior to treatment, but even there the doctors agree we can allow for a 151 size, inflamed prostate raising PSA.
Your discussion of the trial was extremely helpful, thank you.
Given that I am 73, and with heart disease, I am alert to comorbitities... and prioritize QOL over length.
So I am trying to understand risk/reward on an absolute, plain English basis. Exaggerating, of course, but does stopping early mean I risk bone metastasis in 6 months, or just that I'm x% more likely to have chemical recurrence in 5 years? That's a wide window, and I'm trying to learn about it.
Thanks again
Ned
Replies to "Thank you, Phil. Yes, I'm planning on 12 months. I'm Gleason 4+3, very small, didn't even..."
Connect
@datasource You should demand a Decipher Score to actually measure the aggressiveness of your cancer. They did not have one when I was diagnosed.
It is totally unscientific and imprecise to call your cancer high risk or aggressive based on your PSA. Men have had PSA’s triple yours and no cancer was found on biopsy.
Especially with a small 4+3, the treatment with ADT all depends on the aggressiveness. I will go one step further and say that if your decipher score comes in very low you may not need ADT at all – and remember this advice is coming from someone who actually wanted it! Best of luck,
Phil